Since the early 1980s, private, for-profit corporations have become increasingly involved in all aspects of scientific research, especially of biomedical research. In this essay, I argue that there are dangerous epistemic consequences of this trend, which should be more thoroughly examined by social epistemologists. In support of this claim, I discuss a recent episode of pharmaceutical research involving the painkiller Vioxx. I argue that the research on Vioxx was epistemically problematic and that the primary cause of these inadequacies was faulty (...) institutional arrangements. More specifically, the research was organized in such a way as to allow short-term commercial interests to compromise epistemic integrity. Thus, the Vioxx case study, in conjunction with numerous case studies developed elsewhere, provides strong reasons for believing that the privatization of the biomedical sciences is epistemically worrisome, and it suggests that the primary response to this situation should be a social, or organizational, one. What kind of organizational response would be most beneficial? I briefly discuss two prominent social epistemological proposals for how scientific research should be organized - namely those of Philip Kitcher and Helen Longino - and I suggest that they are incapable of dealing with the phenomenon of privatization. I then draw upon the Vioxx episode in order to outline an alternative suggestion for reorganizing certain aspects of pharmaceutical research. (shrink)

Philosophers of science have in recent years presented arguments in favour of increasing cognitive diversity, diversity of social locations, and diversity of values and interests in science. Some of these arguments align with important aims in contemporary science policy. The policy aims have led to the development of institutional measures and instruments that are supposed to increase diversity in science and in the governance of science. The links between the philosophical arguments and the institutional measures have not gone unnoticed. Philosophers (...) have even explicitly suggested that institutional measures could be used to increase diversity in science. But philosophical criticisms of the existing institutional instruments have also been presented. Here I review some recent case studies in which philosophers examine actual attempts to increase diversity in science by using institutional measures implemented from the top down—attempts that have failed in one way or another. These studies examine attempts to involve citizens or stakeholders in the governance of science and technology and attempts to increase the number of interdisciplinary collaborations. They draw attention to the limitations of such instruments, calling into question the most optimistic visions of using institutional instruments to increase diversity in science. (shrink)